NDAINJECTIONINJECTABLE
Approved
Oct 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
DECA-DURABOLIN (nandrolone decanoate) by Teva is clinical pharmacology anabolic steroids are synthetic derivatives of testosterone. First approved in 1962.
Drug data last refreshed 36m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DECA-DURABOLIN (nandrolone decanoate) is a synthetic anabolic steroid derived from testosterone, administered via intramuscular injection. It works by mimicking male sex hormone effects to promote anabolic (muscle-building) and androgenic (masculinizing) properties. The drug is indicated for conditions requiring anabolic support, though complete separation of anabolic and androgenic effects has not been achieved.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), suggesting reduced team investment and focus on generic transition planning.
Mechanism of Action
CLINICAL PHARMACOLOGY Anabolic steroids are synthetic derivatives of testosterone. Certain clinical effects and adverse reactions demonstrate the androgenic properties of this class of drugs. Complete dissociation of anabolic and androgenic effects has not been achieved. The actions of anabolic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
38 enrolled
HIV InfectionsHIV Wasting Syndrome
Career Relevance
Working on DECA-DURABOLIN offers limited career growth in a LOE-approaching product with minimal linked job openings (0 positions). Professionals on this brand should expect focus on compliance, generic transition strategy, and cost management rather than launch or growth initiatives.
Worked on DECA-DURABOLIN at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.